Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

Abstract Background Human epidermal growth factor receptor 2 (HER2), a promising therapeutic target, can be mutated, amplified, or overexpressed in different malignancies, including non-small cell lung cancer (NSCLC). Although these alterations showed adverse prognostic effects in many cancers, thei...

Full description

Bibliographic Details
Main Authors: Ola Abu Al Karsaneh, Arwa Al Anber, Mohammad ALQudah, Sahar Al-Mustafa, Hussien AlMa’aitah, Maher Sughayer
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Diagnostic Pathology
Subjects:
Non-small cell lung cancer
Epidermal growth factor receptor
HER2
Survival, Immunohistochemistry
Jordan
Online Access:https://doi.org/10.1186/s13000-023-01364-2

Internet

https://doi.org/10.1186/s13000-023-01364-2

Similar Items